Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vyas

Showing results (331-340 of 357) with videos related to

Pageof 36
Sort By:
Journal of Clinical Pharmacology|January 13, 2000
Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjectsM R Goldberg, Y Lee, K P Vyas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouseK P Vyas, P H Kari, S M Pitzenberger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 25, 2000
Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 productionM G Attur, R Patel, G Thakker, et al.
British Journal of Clinical Pharmacology|July 17, 2001
Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprololM R Goldberg, D Sciberras, M De Smet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosisD R Moller, J D Forman, M C Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2001
Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniquesT A Baillie, R A Halpin, B K Matuszewski, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of intravenous alendronateV Cocquyt, W F Kline, B J Gertz, et al.
Journal of AOAC International|May 20, 2010
Determination of immunoglobulin G in bovine colostrum and milk powders, and in dietary supplements of bovine origin by protein G affinity liquid chromatography: collaborative studyGrant Abernethy, Don Otter, K Arnold, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
In vitro and in vivo studies on the metabolism of tirofibanS Vickers, A D Theoharides, B Arison, et al.
Pageof 36

Showing results (331-340 of 357) with videos related to

Sort By:
Pageof 36
Journal of Clinical Pharmacology|January 13, 2000
Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjectsM R Goldberg, Y Lee, K P Vyas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouseK P Vyas, P H Kari, S M Pitzenberger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 25, 2000
Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 productionM G Attur, R Patel, G Thakker, et al.
British Journal of Clinical Pharmacology|July 17, 2001
Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprololM R Goldberg, D Sciberras, M De Smet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosisD R Moller, J D Forman, M C Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2001
Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniquesT A Baillie, R A Halpin, B K Matuszewski, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of intravenous alendronateV Cocquyt, W F Kline, B J Gertz, et al.
Journal of AOAC International|May 20, 2010
Determination of immunoglobulin G in bovine colostrum and milk powders, and in dietary supplements of bovine origin by protein G affinity liquid chromatography: collaborative studyGrant Abernethy, Don Otter, K Arnold, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
In vitro and in vivo studies on the metabolism of tirofibanS Vickers, A D Theoharides, B Arison, et al.
Pageof 36